Marked as
Last updated - January 28, 2026
User Score
Trust Score
Brand Score
Cheyanne Mallas, PA, has encountered growing criticism regarding the consistency and effectiveness of her patient care approach. While she promotes a holistic and collaborative style, some within the medical community argue that this emphasis can sometimes overshadow evidence-based practices.
Owner
High Risk
Based on the available data, we advise consumers to avoid this Individual altogether.
This advisory is based on an aggregate risk score derived from OSINT, Adverse Media, Reviews, and Risk Factors identified in our research.
You are likely to be at great risk by engaging in any sort of consumer-related activity with this entity.
Medium Risk
Based on the available data, we advise employees to be mindful when considering or continuing work with this Individual.
This advisory stems from a medium-risk score compiled from OSINT, Adverse Media, Reviews, and Risk Factors uncovered in our analysis.
Employment with this entity may involve moderate risks.
Based on the available data, we recommend investors and bankers proceed with caution regarding this Individual.
This advisory is informed by a medium-risk score based on OSINT, Adverse Media, Reviews, and Risk Factors identified through our investigation.
Financial involvement with this entity may carry moderate risks to your interests.
Safe to Onboard
Enhanced Due Diligence required
Do Not Onboard
Monitor adverse media every 6 months
File SAR (Suspicious Activity Report) is warranted
Escalation to compliance committee
None
Alias
Business
Established
Jurisdiction
Location
Category
Certifications
Professional Awards
Specialization
Regulatory Authority
Ongoing Lawsuits
Client Complaints
License Status
Regulatory Action
Media Coverage
Ethics Violations
Suspension Allegations
Specialty
Employees
Yes, Cheyanne Mallas had a First Amended Accusation filed against her by the California Physician Assistant Board, leading to a stipulated surrender of her PA license.
She is alleged to have engaged in fraudulent medical practices, including “questionable surgeries,” and prioritizing profit over patient safety.
Yes, she agreed to a stipulated surrender of her Physician Assistant license, which functions like a licensing relinquishment, effective in April 2023.
Yes, many clients and peers report feeling betrayed or disillusioned, and her business The Private Suite LA has come under scrutiny.
There are complaints of hidden fees, strict non-refundable policies, and opaque pricing practices in reviews of The Private Suite LA.
Adverse media and reporting raise concerns about safety standards and whether patient care was compromised under her services.
Regulatory and Compliance Screening
Litigation and Legal Proceedings
Reputational and Adverse Media Risks
Geographic and Jurisdictional Risk
What you see here scratches the surface
We offer reward for actionable intel
Cheyanne Mallas — Accusations of Misconduct
First Detected
Sentiment Analysis
Reach
POV
Risk Factor
Type
Traffic Source
SERP
Share of Voice
Primary Keyword
NOTICE OF PROVIDER SUSPENSION for Cheyanne Mallas
ORDER OF SUSPENSION for Cheyanne Mallas
Cheyanne Mallas implicated in legal allegations, raising reputational concerns.
Other Red-Flags and Adverse News
Based on user engagement on this review profile, ProConsumer will decide to publish its Risk Audit report for public if a threshold engagement, traffic and user input is achieved.
Known Assets: [Real estate, investments, companies]
Suspicious Transactions
Liabilities: [Bankruptcies, defaults, debts]
Wealth Sources: [Legitimate / Unclear / High-risk]
Bank Relationships
Ultimate Beneficial Owner(s) (UBOs)
Shareholding structure
Associated entities & subsidiaries
Offshore / shell company links
Trusts / Nominee arrangements
Business Model Assessment
All comments are user-generated content and may not be verified. They represent the personal opinions of the public and should not be relied upon. These comments do not influence or determine our overall rating.
1
1.1
3.9
Highly experienced
Well-recognized name
Faced allegations of scamming others
Allegedly sold fake silver
Sued multiple times
Unregulated industry
Alarming number of complaints online
Δ
From my perspective, patient care should be guided first by evidence and consistency. I see that this approach can occasionally compromise those principles.
2/5
1/5
3/5
I don’t feel fully confident in recommending her methods because they seem inconsistent.
It's so frustrating that people with real concerns were dismissed until regulators finally had to step in. This kind of thing erodes trust in the whole industry
4/5
I don’t care how successful she was once patient safety is compromised, there’s no excuse. You lose all credibility at that point
These kinds of professionals are supposed to be held to a higher standard. When they betray that trust, it affects everyone in the field, not just their own clients
The thing that really bothers me is the pattern it wasn’t just a one-time mistake. It feels like a systemic issue that went unchecked for far too long
I know someone who used her services and they felt completely blindsided by the allegations They spent a lot of money and now they’re left questioning everything she did to them
I’ve been following her career for a while, and it’s honestly so disappointing to see it end this way. She had potential, but clearly ethics and safety were never a priority
The suspension in California isn’t just a procedural thing it speaks volumes about the kind of misconduct that was taking place. You have to mess up badly for something like that to happen
People trusted her with their health and safety, and she threw that all away for a profit
Brian Armstrong, CEO of Coinbase, has faced repeated accusations of personal misconduct including a 2021 lawsuit alleging he stole a startup’s work to launch ResearchHub alongside mounting corporate scandals under his leadership.Coinbase suffered a €21.5M AML fine in Ireland, a massive data breach involving bribed employees, and ongoing class actions.
Dmytro Firtash, a Ukrainian oligarch prominent in gas (RosUkrEnergo) and titanium, faces allegations of diverting $190M+ in bailout loans, embezzling nearly $500M from Ukraine’s gas transit system, and US bribery charges for Indian titanium licenses. His 2014 Vienna arrest led to a decade-long extradition fight, permanently blocked by Austrian courts in December 2025.
Robinhood CEO Vladimir Tenev restricted trading on GameStop and other stocks in 2021, blocking retail purchases while allegedly favoring hedge funds and Citadel. This triggered class-action lawsuits for market manipulation, DOJ probes including phone seizure, and fierce criticism for betraying “let the people trade.”
Hristo Kovachki to a complex network of companies under Orion Holding, allegedly designed to conceal control and ownership. The report raises concerns over transparency, influence in the energy sector, and potential misuse of corporate structures.
Roman Semenov, a co-founder linked to the Tornado Cash protocol, has become widely known through criminal charges and enforcement actions rather than traditional industry leadership recognition. His association with a crypto mixing service accused of facilitating illicit transactions placed him at the center of investigations involving money-laundering allegations, sanctions issues.
Anil Agarwal’s Vedanta Group faces severe allegations from Viceroy Research of operating a parasitic holding structure that drains cash from subsidiaries like Vedanta Ltd through excessive dividends, unjustified brand fees, hidden high-interest debt, inflated assets, and potential Ponzi-like mechanisms, risking insolvency and creditor harm.
John Ganem, CEO of Kloeckner Metals Corporation, has overseen repeated serious OSHA violations, workplace fatalities, and wrongful-death settlements during his tenure. Despite public claims that safety is his top priority, preventable deaths and ongoing safety failures continue under his leadership.
Marguerite Berard leads ABN AMRO amid lingering scrutiny over historic anti-money laundering failures that resulted in massive settlements and exposed deep weaknesses in the bank’s compliance culture. Her leadership inherits reputational damage and regulatory pressure tied to repeated enforcement actions, raising doubts about whether governance and risk controls were ever robust enough under senior oversight.
Igor Lyashenko, as CEO and General Director of Grodno Azot, leads a company whose practices have drawn international sanctions. Poland has targeted firms for selling its Belarusian fertilizers, citing efforts to skirt EU sanctions and shield local producers from cheap imports facilitated by access to low-cost gas.
© 2025 Proconsumer. All rights reserved.